In the middle stage of IBD research, various pathophysiological processes related to the microbiota and IBD have gradually become the focus of research, including aspects such as the gut microbiome, NF-κB, innate immunity, regulatory T cells, and barrier function, which indicates that the research on the effect of dietary habits on IBD is deepening. The gene discussed is NFKB1; the disease is inflammatory bowel disease.